Covestor’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Covestor's STOK Position: Q3 2026 in Review
Covestor reduced its Stoke Therapeutics (STOK) stake by 38% in Q3 2026, selling an estimated $181 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2807.
Covestor first reported a position in STOK in Q1 2025 and has held it in 4 quarters since. The position peaked at $16K in Q1 2025. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Covestor held 10 shares of Stoke Therapeutics worth $0 as of Q3 2026.
- Covestor sold 6 Stoke Therapeutics shares in Q3 2026, an estimated $181.
- Stoke Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2807 holding.
- Covestor first reported a position in Stoke Therapeutics in Q1 2025 and has held it in 4 quarters since.
- Covestor's Stoke Therapeutics position peaked at $16K in Q1 2025.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.